Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04380324 · ClinicalTrials.gov registry record · Phase 1
A Study of NKTR-358 (LY3471851) in Healthy Participants
A Phase 1 study, sponsored by Nektar Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 100
- Enrollment target
NCT04380324 is a Phase 1 study that has completed, run by Nektar Therapeutics. The registered enrollment target is 100 participants.
The verdict
NCT04380324, a Phase 1 study, has completed, sponsored by Nektar Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 100 participants
- Enrollment target
Study Summary
The main purpose of this study is to evaluate the safety and tolerability of a study drug known as LY3471851 in healthy participants. The study will last about 50 days for each participant.
Interventions
- DRUG Placebo
- DRUG LY3471851
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-03-19 |
| Est. Completion | 2019-01-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04380324
The ClinicalTrials.gov registry entry for NCT04380324 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nektar Therapeutics, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04380324 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04380324 about?
NCT04380324 is a clinical study titled "A Study of NKTR-358 (LY3471851) in Healthy Participants". The main purpose of this study is to evaluate the safety and tolerability of a study drug known as LY3471851 in healthy participants. The study will last about 50 days for each participant.
What is the current status of trial NCT04380324?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 100 participants. The study started on 2017-03-19. Estimated completion is 2019-01-20.
What interventions are being tested in trial NCT04380324?
The interventions under investigation include: Placebo (DRUG), LY3471851 (DRUG).
Who is sponsoring clinical trial NCT04380324?
This trial is sponsored by Nektar Therapeutics, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.